Showing 321-330 of 21402 results for "".
- Leveraging Community Leaders and Churches to Tackle Type 2 Diabetes in Rural Areashttps://reachmd.com/news/leveraging-community-leaders-and-churches-to-tackle-type-2-diabetes-in-rural-areas/2468765/Rural communities face unique challenges in accessing healthcare and prevention resources, contributing to rising rates of Type 2 diabetes. A recent study from the University of Georgia highlights a promising solution: involving local leaders and churches in delivering diabetes prevention program
- Genetics Predict Type 2 Diabetes Risk and Disparities in Childhood Cancer Survivorshttps://reachmd.com/news/genetics-predict-type-2-diabetes-risk-and-disparities-in-childhood-cancer-survivors/2462854/Genetics amplify diabetes risk from alkylating agents in survivors The research also suggested that another contributor to increased type 2 diabetes risk is exposure to alkylating agents, a class of chemotherapy commonly used in childhood cancer treatments. “We s
- AVAnT1A Study: Investigating Early COVID-19 Vaccination and Type 1 Diabetes Risk in Childrenhttps://reachmd.com/news/avant1a-study-investigating-early-covid-19-vaccination-and-type-1-diabetes-risk-in-children/2462996/Type 1 diabetes is an autoimmune disease that leads to disrupted glucose metabolism. It requires lifelong insulin therapy. The Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) collaborates within a European network to develop new
- Mitigating CGM Alarm Fatigue in Pediatric Type 1 Diabeteshttps://reachmd.com/news/cgm-alarm-fatigue-pediatric-type-1-diabetes/2484804/Continuous glucose monitoring (CGM) alarm fatigue is emerging as a leading barrier to sustained device use for children with type 1 diabetes and their caregivers. The literature document
- Telemedicine for Type 2 Diabetes: Meta-analysis Shows HbA1c and Cardiometabolic Benefitshttps://reachmd.com/news/telemedicine-for-type-2-diabetes-meta-analysis-shows-hba1c-and-cardiometabolic-benefits/2485748/A systematic review and meta-analysis of randomized trials in adults with type 2 diabetes compared telemedicine interventions with usual care and reported a pooled reduction in HbA1c favoring tel
- Exploring Peptide YY as a Potential Adjunct in Type 2 Diabetes Managementhttps://reachmd.com/news/exploring-peptide-yy-as-a-potential-adjunct-in-type-2-diabetes-management/2484317/Peptide YY is emerging as a validated gut‑hormone adjunct to complement GLP‑1 therapy in type 2 diabetes—improving insulin sensitivity and moderating appetite while avo
- Addressing Parental Anxiety in Pediatric Type 1 Diabetes Managementhttps://reachmd.com/news/addressing-parental-anxiety-in-pediatric-type-1-diabetes-management/2475901/Clinicians often grapple with parental anxiety over hypoglycemia in managing pediatric Type 1 Diabetes, where well-intentioned fear can drive insulin dosing that strays from optimal glycemic t
- Reframing Muscle Preservation in Type 2 Diabetes: Beyond Glycemic Controlhttps://reachmd.com/news/reframing-muscle-preservation-in-type-2-diabetes-beyond-glycemic-control/2475636/Muscle mass reduction is a commonly observed complication in type 2 diabetes, impacting patient health and quality of life. Recent discoveries have unveiled molecular links and metabolic dysfunctions crucial for novel intervention strategies.
- Emerging Roles of Coffee Polyphenols in Type 2 Diabetes Managementhttps://reachmd.com/news/emerging-roles-of-coffee-polyphenols-in-type-2-diabetes-management/2475449/Amidst the search for holistic strategies, emerging data are revealing how coffee’s polyphenolic compounds could enhance glycemic stability and attenuate inflammation in type 2 diabetes management. As primary care physicians and endocr
- Emerging Biomarkers in Type 2 Diabetes: A New Horizon in Early Diagnosishttps://reachmd.com/news/emerging-biomarkers-in-type-2-diabetes-a-new-horizon-in-early-diagnosis/2474920/Recent research suggests that emerging molecular signatures and neuroproteins may improve type 2 diabetes care by offering tools that could help diagnose insulin resistance earlier and assess cognitive decline risk, using markers linked with